StonvexLoading…
StonvexStonvexStonvexCore line items from LTH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $854.60M | $788.70M | $3.00B | $2.25B | $1.47B |
Operating Income | Not available | $134.84M | $481.29M | $351.76M | $216.12M |
Net Income | Not available | $88.10M | $373.67M | $250.67M | $148.24M |
EPS (Diluted) | $0.40 | $0.39 | $1.66 | $1.11 | $0.66 |
Total Assets | Not available | $8.11B | $8.01B | $7.83B | $7.60B |
Total Liabilities | Not available | $4.89B | $4.88B | $4.84B | $4.73B |
Cash & Equivalents | Not available | $119.95M | $204.81M | $218.90M | $175.51M |
Free Cash Flow OCF − CapEx | Not available | $-61.22M | $-20.96M | $43.69M | $15.07M |
Shares Outstanding | Not available | 222.45M | 221.08M | 220.26M | 219.90M |